Tag: tarek alhamad

Suleiman and Alhamad Awarded WU Nephrology 2017 Translational Innovation Grant

The Division of Nephrology’s 2017 Translational Innovation Grant has been awarded to Assistant Professor of Medicine Tarek Alhamad, MD, and Instructor of Medicine Hani Suleiman, MD, PhD, in the sum of $50,000.  The project is titled Novel Diagnostic Imaging Techniques for Transplant Glomerulopathy. The Translational Innovation Grant program, now in its third year, brings together a clinician and basic scientist from […]

Washington University and BJH Mark 5,000 Adult Kidney Transplants

The Washington University and Barnes-Jewish Hospital kidney transplant program, one of the largest and oldest in the United States, celebrated a milestone in 2017: the 5000th patient to receive an adult kidney. The program began in 1963, with the first living kidney donor transplant performed in 1965. The team generally averages more than 230 kidney […]

Sreelatha Katari and Mallika Gupta 2018 Transplant Fellows

The Transplant Nephrology Fellows have been announced for the 2018-2019 academic year. Sreelatha Katari, MD, currently a second year fellow in the Division of Nephrology here at Washington University, and Mallika Gupta, MD, a second year nephrology fellow at the University of Washington in Seattle, will join the transplant training program next year. The one-year […]

A Warm Welcome for Devin Wall – A Tech Who Really Knows How to Chill

The Division of Nephrology gives a warm welcome to research technician Devin Wall, who will assist Drs. Tarek Alhamad and Andrew Malone with the Clinical Trials in Organ Transplantation (CTOT-19) project and the Kidney Translational Research Core (KTRC) biobanking program. Dr. Alhamad, Assistant Professor of Medicine and Interim Medical Director of the Kidney Transplant Program, […]

The Surprising Relationship Between BMI and Liver Transplantation Mortality

Many transplant programs decline liver transplantation (LT) to obese candidates because they have a higher risk of surgical complications and death than do non-obese candidates. In addition, obese candidates have longer waiting times for LT. However, studies examining the association of a recipient’s body mass index (BMI) and post LT-mortality have not produced consistent results. […]

Save the Date: Midwest Transplant Symposium September 8-10

“It is never too late to learn something new!” says Tarek Alhamad, MD, MS, who is Course Chair for the upcoming 3rd Midwest Transplant Symposium on September 8-10, 2017, at Washington University School of Medicine. The symposium is designed for health care professionals including physicians in training, pharmacists, transplant coordinators, surgical assistants, nurses, and nephrologists […]

The Center Effect: Transplants and Patient Survival

Pancreas transplantation is an effective, long-term treatment for patients with type 1 diabetes mellitus. For patients with diabetes mellitus and end stage renal disease (ESRD), simultaneous pancreas-kidney (SPK) transplantation improves patient and allograft survival compared to deceased donor kidney transplant alone. A recent study in Transplantation headed by Assistant Professor of Medicine Tarek Alhamad, MD, […]

Tarek Alhamad to Serve on KPCOP Executive Committee

Division of Nephrology Assistant Professor of Medicine Tarek Alhamad has been elected to serve a two-year term as a Committee Member-at-Large on the Kidney Pancreas Community of Practice (KPCOP) Executive Committee. Members of the KPCOP Executive Committee advise the American Society of Transplantation (AST) Board of Directors on its goal of promoting research, education, advocacy, […]

Non-Invasive Screening Tool for Alport Syndrome

A novel method to diagnose X-linked Alport Syndrome has been developed and validated in a recent study by Andrew Malone, MBBCh, Steven Funk, PhD, Tarek Alhamad, MD and Jeffrey Miner, PhD, in the Division of Nephrology. Alport syndrome is an inherited disease characterized by a progressive loss of kidney function, hearing loss and eye abnormalities, […]

Pancreas-Kidney from Mildly Obese Donor Safe for Transplantation

Obesity, described as a body mass index (BMI) greater or equal to 30 kg/m2, is global epidemic. More than a third of the adults in the United States are considered obese. Organs from obese individuals are often not accepted for transplantation due to concerns of suboptimal organ quality and inferior allograft survival. This greatly affects […]